N,N-Dimethyltryptamine
Sponsors
Algernon Pharmaceuticals, Biomind Labs Inc., Universidade Federal do Rio Grande do Norte, University Hospital, Basel, Switzerland
Conditions
Depression, UnipolarDepressive DisorderHealthy VolunteersMajor Depressive DisorderPsychedelic ExperiencesSafety IssuesStroke
Phase 1
Single and Repeat Doses of DMT in Healthy Subjects
Active, not recruitingNCT05559931
Start: 2023-01-13End: 2026-03-31Target: 60Updated: 2025-01-28
Clinical Study of DMT in Healthy Adults
CompletedNCT05573568
Start: 2022-06-01End: 2022-11-14Updated: 2023-02-15
Safety and Tolerability of DMT in Healthy Adults
CompletedNCT05901012
Start: 2023-04-26End: 2023-07-17Updated: 2023-10-11